Beta-Amyloid Bri (1-23) - 1 mg
- Cat.Number : AS-65579
- Manufacturer Ref. :
-
Availability :
In stock
Select specification
Amyloid Bri (1-23) and Amyloid Bri (1-34) peptides are post-translational products of mutated BRI2 gene. Amyloid Bri peptides are found as plaques in brains of patients with Familiar British Dementia (FBD) that shares many common features with Alzheimer’s Disease.
Pyroglutamyl (pGlu) peptides may spontaneously form when either Glutamine (Q) or Glutamic acid (E) is located at the sequence N-terminus. The conversion of Q or E to pGlu is a natural occurrence and in general it is believed that the hydrophobic γ-lactam ring of pGlu may play a role in peptide stability against gastrointestinal proteases. Pyroglutamyl peptides are therefore considered a normal subset of such peptides and are included as part of the peptide purity during HPLC analysis.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)



References
Conformational analysis of peptides derived from the BRI gene
Spectroscopy . 2001 Jan 20 ; 15 129
- V. Lelyveld
- et al
The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers
J Biol Chem, . 2015 Jul 01 ; 290(27) 16502 | DOI : https://doi.org/10.1074/jbc.M115.652263
- A. Cantlon
- et al